Hemas Holdings PLC on Tuesday announced changes to its Board of Directors, with the stepping down of its chairman Husein Esufally, reflecting the group’s commitment to strong governance and a seamless leadership transition.
Mr. Esufally, who has served Hemas for over four decades in various leadership capacities including Group Chief Executive Officer and Chairman, will retire from the Board with effect from December 31, 2025. Under his stewardship, Hemas evolved into one of Sri Lanka’s most respected and diversified conglomerates, delivering consistent value to stakeholders. The Board of Directors and the Hemas Group expressed its profound appreciation for his vision and dedication, which have been instrumental in shaping the group’s purpose-driven culture and long-term success, the company said in an announcement.
Dr. Anura Ekanayake, Deputy Chairman, will also retire on December 31, upon completion of his term. Dr. Ekanayake’s contributions to the Board and the group have been significant, particularly in strengthening governance and providing strategic counsel during periods of transformation.
Mr Ajith Fernando will from January 1, 2026 take over as chairman of the group. A veteran in investment banking with over 30 years of experience, Mr. Fernando is widely recognized for his strategic insight and disciplined execution.
Mr. Murtaza Esufally, current Chairman of the Healthcare cluster, has been appointed Deputy Chairman of Hemas Holdings PLC, effective January 1, 2026. His deep industry expertise and longstanding leadership within the group will support Hemas’ strategic priorities and governance framework.
Leave Comments